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ABSTRACT 24 
Objective 25 
To investigate the demographic, symptomatic, clinical and structural foot 26 
characteristics associated with potential phenotypes of midfoot osteoarthritis (OA). 27 
Design 28 
Cross-sectional study of 533 community-dwelling adults DJHG\HDUVwith foot 29 
pain in the past year. Health questionnaires and clinical assessments of symptoms, 30 
foot structure and function were undertaken. Potential midfoot OA phenotypes were 31 
defined by the pattern of radiographic joint involvement affecting either the medial 32 
midfoot (talonavicular, navicular-1st cuneiform, or cuneiform-1st metatarsal joint), 33 
central midfoot (2nd cuneiform-metatarsal joint), or both medial and central midfoot 34 
joints. Multivariable regression models with generalised estimating equations were 35 
used to investigate the associations between patterns of midfoot joint involvement 36 
and symptomatic, clinical and structural characteristics compared to those with no or 37 
minimal midfoot OA. 38 
Results 39 
Of 879 eligible feet, 168 had medial midfoot OA, 103 central midfoot OA, 76 both 40 
medial and central midfoot OA and 532 no/minimal OA. Having both medial and 41 
central midfoot OA was associated with higher pain scores, dorsally-located midfoot 42 
pain (OR 2.54, 95%CI 1.45, 4.45), hallux valgus (OR 1.76, 95%CI 1.02, 3.05), flatter 43 
foot posture ȕ&,, lower medial arch height ȕ 0.02, 95%CI 44 
0.01, 0.03) and less subtalar inversion and 1st MTPJ dorsiflexion. Isolated medial 45 
midfoot OA and central midfoot OA had few distinguishing clinical characteristics. 46 
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Conclusions 47 
Distinct phenotypes of midfoot OA appear challenging to identify, with substantial 48 
overlap in symptoms and clinical characteristics. Phenotypic differences in 49 
symptoms, foot posture and function were apparent in this study only when both the 50 
medial and central midfoot were involved. 51 
Keywords: foot, osteoarthritis, phenotype, midfoot, pain, function 52 
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INTRODUCTION 77 
Foot osteoarthritis (OA) is increasingly recognised as an important contributor to the 78 
burden of OA, affecting 1 in 6 adults aged over 50 years, with a significant negative 79 
impact on physical mobility and quality of life1-3. The most commonly affected foot 80 
joint is the first metatarsophalangeal (1st MTP; 7.8%), followed by the midfoot, 81 
including the second cuneiform-metatarsal (2nd CMJ; 6.8%), talonavicular (TNJ; 82 
5.8%), navicular-first cuneiform (NCJ; 5.2%) and first cuneiform-metatarsal joints (1st 83 
CMJ; 3.9%)1.  84 
Midfoot OA has been recognised as a distinct subtype of foot OA, with recent 85 
findings indicating the presence of two main phenotypes of radiographic foot OA 86 
based on the pattern of joint involvement4. The first is isolated 1st MTPJ OA with 87 
minimal midfoot involvement, and the second is polyarticular OA affecting both the 1st 88 
MTPJ and midfoot joints (TNJ, NCJ and CMJs). Polyarticular foot OA is the most 89 
disabling form of foot OA4 and is associated with foot pain, obesity, previous injury, 90 
lower medial arch height and pain in other weight-bearing joints2, 4, 5. The significant 91 
impact that midfoot OA has on physical function is, in part, attributed to the important 92 
role the midfoot has in distributing load in the foot during weight-bearing activities 93 
such as walking6, standing7 and stair climbing8. Progression towards significant flat-94 
foot deformity with advanced midfoot OA also results in complaints of unusual foot 95 
posture and difficulty with footwear fitting9.  96 
Because the midfoot has a complex structure with many articulations, it is possible 97 
that distinct patterns of involvement exist. Indeed, results from a data-driven 98 
approach used to identify subgroups of foot OA from a large, population-based 99 
cohort identified two main clusters of foot OA (polyarticular and 1st MTPJ), and raised 100 
the possibility of two subsets of midfoot OA existing; one affecting the medial midfoot 101 
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joints only (TNJ, NCJ or 1st CMJ) and the other the central midfoot only RUµVHFRQG102 
UD\¶ (2nd CMJ)4.  103 
The potential presence of two subgroups of midfoot OA may be explained, in part, by 104 
differences in the function of the medial versus central joints of the midfoot. The most 105 
medial part of the midfoot, involving the joints along the medial arch such as the TNJ, 106 
1st NCJ, and 1st CMJ (first ray), is highly mobile during walking and becomes loaded 107 
dorsally when the arch flattens6. This is in contrast to the 2nd CMJ which contributes 108 
less to medial arch stability, is tightly bound, and displays minimal motion7, 10. 109 
Anatomically, the 1st CMJ and 2nd CMJ also typically have separate synovial 110 
compartments11, 12 further reinforcing their distinction as separate functional entities 111 
in the medial and central regions of the midfoot. It is therefore plausible that the 112 
mechanisms underlying the development of these two subgroups of midfoot OA 113 
differ, which may be reflected in the clinical and structural foot characteristics 114 
observed in clinical practice. Existing studies have not been able to adequately 115 
investigate patterns of OA within the midfoot and their associations with clinical 116 
features due to a focus on either the tarsometatarsal or medial midfoot joints, small 117 
sample sizes or a narrow range of measured clinical characteristics8, 13-17. There 118 
have been no prior studies investigating potential phenotypes specifically in the 119 
midfoot, nor any association with clinical characteristics.  120 
Characterising midfoot OA and potential phenotypes in greater detail will improve our 121 
understanding of their clinical presentation and may offer early insights into the 122 
mechanisms involved in disease pathogenesis. This line of research is also attractive 123 
as a basis for developing targeted or stratified interventions for different types of foot 124 
OA in the future, two areas identified as key OA research priorities by the European 125 
League Against Rheumatism (EULAR)18. The aim of this study was to investigate the 126 
6 
 
demographic, symptomatic, clinical and structural foot characteristics associated with 127 
potential phenotypes of midfoot OA based on different patterns of joint involvement; 128 
medial midfoot OA only (TNJ, NCJ or 1st CMJ), central midfoot OA only (2nd CMJ) 129 
and combined medial and central midfoot OA. 130 
METHODS 131 
Study design and population 132 
This study was a cross-sectional analysis of baseline data from the Clinical 133 
Assessment Study of the Foot (CASF), a large prospective observational cohort 134 
study in North Staffordshire, UK19. Health Survey questionnaires were mailed to 135 
patients aged 50 years and over registered with four general practices. Individuals 136 
who responded and indicated they had foot pain in the last 12 months were invited to 137 
attend a research clinic for a clinical assessment and plain radiography of both feet. 138 
Participants were excluded from the current analyses if their medical records or 139 
radiology report identified them as having inflammatory arthritis (rheumatoid arthritis, 140 
psoriatic arthritis or non-specific inflammatory arthritis). All participants provided 141 
written informed consent and ethical approval was granted for this study from 142 
Coventry Research Ethics Committee (REC reference number: 10/H1210/5). 143 
Data Collection 144 
Health Survey Questionnaire 145 
The Health Survey questionnaire included items on demographics and socio-146 
economic status (age, sex, education, occupation), general health, foot pain and 147 
symptoms (pain in the last 12 months, pain severity in the last month using a 0-10 148 
numerical rating scale [NRS], duration of pain, and the Manchester Foot Pain and 149 
Disability Index (MFPDI)20). Foot pain location was recorded by participants marking 150 
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or shading the corresponding area on a foot manikin21, 22 (© The University of 151 
Manchester 2000, all rights reserved). Dorsal and plantar midfoot pain were then 152 
determined according to the region(s) selected. Raw MFPDI pain and function scores 153 
were converted to Rasch-transformed logit values for statistical analysis23. The 154 
presence of hallux valgus was determined from validated self-report line drawings 155 
obtained during the questionnaire24, with the three most severe depictions graded as 156 
present and the two least severe as absent25. 157 
Clinical assessment 158 
Physical and clinical assessments (foot posture, range-of-motion and deformity) were 159 
undertaken on all participants who attended the research clinic according to 160 
standardised protocols by one of seven trained therapists (podiatrist or 161 
physiotherapist)19. Pre-study training and quality control measures were undertaken 162 
throughout the study19. Anthropometric measurements (height and weight) were 163 
taken, and body mass index (BMI) subsequently derived. Foot posture was assessed 164 
with participants in a relaxed standing position using the Foot Posture Index (FPI)26, 165 
Arch Index (AI)27 and Navicular Height (NH), with NH being normalised to the total 166 
foot length28. The FPI is a six-item observational rating tool for the assessment of 167 
overall foot posture, with each item corresponding to an individual feature and graded 168 
from -2 (supinated) to +2 (pronated) for maximum scores ranging from -12 (highly 169 
supinated) to +12 (highly pronated)26. Raw scores were converted to Rasch-170 
transformed logit values for statistical analysis29. The AI was derived from carbon 171 
paper footprints and is defined as the ratio of the area of the middle third of the foot 172 
to the total footprint area (minus the toes)27. Higher AI values indicate a more 173 
flattened medial foot arch. Measurement of NH was taken by marking the navicular 174 
tuberosity with a pen, measuring its height from the supporting surface with a ruler (in 175 
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millimetres), and dividing this value by the total length of the foot. Lower NH values 176 
indicate a flatter medial foot arch28. Values for the FPI and AI were also presented in 177 
categories based on established cut-points30, 31, with NH values categorised in tertiles 178 
according to the variable distribution. 179 
Range-of-motion at the ankle joint was assessed with an inclinometer using the 180 
weight bearing lunge test with the knee flexed and extended32, 33. Subtalar/ankle 181 
inversion and eversion were assessed with the participant non-weight-bearing using 182 
a goniometer34. Non-weight bearing dorsiflexion range-of-motion of the 1st MTPJ was 183 
also assessed using a flexible goniometer35. Midfoot exostosis was documented as 184 
the presence or absence of a bony prominence on the dorsum of the foot in non-185 
weight bearing.  Reliability of foot posture and clinical tests has previously been 186 
reported28, 32-35.  187 
Radiographic assessment and scoring 188 
Participants had weight-bearing dorsoplantar and lateral radiographs of both feet 189 
taken according to a standardised protocol36. Radiographs were graded separately 190 
for joint space narrowing (JSN) and osteophytes (OP) in four midfoot joints (TNJ, 191 
NCJ, 1st CMJ and 2nd CMJ) and the 1st MTPJ by a single reader (M.M.). 192 
Radiographic OA of a foot joint was GHILQHGDVJUDGHIRURVWHRSK\WHV23RUMRLQW193 
space narrowing (JSN) on either dorsoplantar or lateral views, as previously 194 
described 36. Intra- and inter-observer reliability (MM and HBM) for scoring within this 195 
dataset have previously been reported as excellent (mean unweighted ț = 0.94, 196 
mean % agreement 99%) and moderate (PHDQXQZHLJKWHGț = 0.46, mean % 197 
agreement 79%), respectively1. 198 
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Four mutually exclusive groups were defined according to the presence of 199 
radiographic OA in the midfoot joints of each foot (Figure 1): 200 
(1) Medial midfoot OA onlyJUDGHIRU-61RU23LQeither the TNJ or NCJ or 201 
1st &0-ZLWKQR2$JUDGHLQWKHnd CMJ. 202 
(2) Central midfoot OA only: JUDGHIRU-61RU23LQWKH2nd CMJ only, with no 203 
OA JUDGHin the TNJ, NCJ and 1st CMJ. 204 
(3) Combined medial and central midfoot OA:  grade IRU-61RU23LQERWKWKH205 
medial midfoot (at least one of the TNJ, NCJ or 1st CMJ) and central midfoot 206 
(2nd CMJ). This group was included to ensure feet with OA involvement across 207 
both regions were included, as we anticipated a significant number of feet with 208 
more extensive involvement. 209 
(4) No or minimal OA: No OA of the midfoot (grade ) for JSN or OP for the TNJ, 210 
NCJ, 1st CMJ and 2nd CMJ.  211 
***Figure 1 here*** 212 
Statistical analysis 213 
Differences between midfoot OA phenotypes were assessed using multivariable 214 
linear regression for continuous outcomes and binary logistic regression for 215 
dichotomous outcomes. All necessary assumptions for the analyses were tested for 216 
and met. Analyses were foot-based, with generalised estimating equations used to 217 
account for between foot correlations within each person and adjusted for age, sex 218 
and BMI. Further adjustment was also made for the presence of 1st MTPJ OA. An 219 
exchangeable working correlation structure was specified for the analysis given the 220 
lack of time-dependent or logical ordering of the data. The no or minimal OA group 221 
were designated as the reference category. Results for continuous outcomes are 222 
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presented as adjusted unstandardised regression coefficients ȕ and considered 223 
statistically significant if the 95% confidence intervals (CI) did not include 0. For 224 
dichotomous outcomes, results are presented as adjusted odds ratios (ORs) with 225 
95% CI and were considered statistically significant if the 95% CI did not include 226 
1.00. All analyses were conducted using SPSS (v21, IBM Corporation, NY, USA). 227 
RESULTS 228 
Descriptive characteristics 229 
Five hundred and sixty people attended the research assessment clinics, of whom 24 230 
had inflammatory arthritis and three did not have foot radiographs, leaving 533 231 
eligible clinic attenders for analysis (mean age 64.9 years SD [8.4], 55% female).  232 
Of the 1066 feet, 532 had no or minimal OA of the midfoot (49.9%), 168 had medial 233 
midfoot OA only (15.7%), 103 had central midfoot OA only (9.6%), and 76 had 234 
combined medial and central midfoot OA (7.1%). Isolated OA of the 1st MTPJ 235 
occurred in 175 feet and with radiographic data were missing for 12 1st MTP joints 236 
(not included in analyses). Compared to the midfoot OA groups, those with isolated 237 
1st MTPJ OA tended to be similar for age, BMI and proportion attending higher 238 
education; whilst having a higher proportion in manual occupations and less self-239 
reported foot pain and better foot function (data not shown). The prevalence of 240 
concurrent 1st MTPJ OA in feet with midfoot OA was 15% (n=134). In feet with medial 241 
midfoot OA, the TNJ was most commonly affected (70%), followed by the NCJ (21%) 242 
and 1st CMJ (19%). In feet with medial and central OA, the most common joints with 243 
OA were the 2nd CMJ (100%) and NCJ (63%), followed by the TNJ (46%) and 1st 244 
CMJ (22%). Twenty of the 879 feet in the analysis (2.2%) had no radiographic 245 
changes (0 for OP or JSN). 246 
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Summary statistics for person and foot-level characteristics according to the different 247 
patterns of midfoot OA involvement are presented in Table 1. Individuals with 248 
combined medial and central midfoot OA tended to be older, had a higher BMI, a 249 
longer duration of symptoms, a higher proportion with manual occupations and a 250 
higher proportion of females compared to the no or minimal midfoot OA group. Those 251 
with central midfoot OA only tended to be older, and those with medial midfoot OA 252 
only had a higher BMI compared to the no or minimal midfoot OA group. 253 
***Table 1 here*** 254 
Clinical characteristics 255 
Multivariable associations between clinical characteristics and midfoot OA groups 256 
adjusted for age, sex, BMI and presence of 1st MTPJ OA are presented in Table 2. 257 
For clarity, only fully adjusted models are presented (partially adjusted regression 258 
models for age, sex and BMI are also provided in Supplementary File 1 for 259 
completeness). 260 
Following adjustment for age, sex, BMI and presence of 1st MTPJ OA, the combined 261 
medial and central midfoot OA group was more likely to report dorsally-located 262 
midfoot pain (OR 2.54; 95% CI 1.46, 4.44), and hallux valgus (OR 1.76; 95% CI 1.02, 263 
3.05) and had higher MFPDI pain scores indicating worse pain (ȕ 0.004, 95% CI 264 
0.0000002, 0.008) compared to the no or minimal OA group. They also displayed a 265 
flatter foot posture, with higher FPI ȕ &,) and AI scores ȕ 266 
0.02; 95% CI 0.01, 0.03) and lower navicular height ȕ -0.01; 95% CI -0.01, -0.002), 267 
and had less subtalar inversion ȕ -2.45; 95% CI -4.41, -0.48) and 1st MTPJ 268 
dorsiflexion ȕ -4.30; 95% CI -8.38, -0.21). Differences in pain severity and foot 269 
posture were relatively small in magnitude compared to the no or minimal OA group. 270 
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Central midfoot OA was associated with higher MFPDI pain scores ȕ 271 
CI 0.0002, 0.008), a higher AI (flatter medial arch) ȕ &,00002, 272 
0.02) and less ankle joint dorsiflexion ȕ -1.464; 95% CI 2.924, -0.005) compared to 273 
the no or minimal OA group, with the magnitude of these associations representing 274 
small effects. The strength of the association between those with central midfoot OA 275 
and the likelihood of reporting dorsal midfoot pain compared to the no or minimal OA 276 
group was similar, but less precise, versus the same association for the combined 277 
medial and central OA group (OR 1.59; 95% CI 0.95, 2.66, P = 0.078). 278 
Medial midfoot OA was associated with increased likelihood of reporting dorsally 279 
located midfoot pain (OR 1.54; 95% CI 1.02, 2.33) and less subtalar inversion ȕ -280 
1.715; 95% CI -2.955, -0.474) compared to the no or minimal OA group. The 281 
direction of association for ankle joint dorsiflexion and subtalar inversion was 282 
opposite for the medial midfoot OA group compared to the central and combined 283 
medial and central groups, with greater ankle joint dorsiflexion and less subtalar 284 
inversion.  285 
***Table 2 here*** 286 
 287 
DISCUSSION 288 
This study aimed to investigate the demographic, symptomatic, clinical and structural 289 
foot characteristics associated with different phenotypes of midfoot OA. Previous 290 
findings have alluded to different phenotypes based on the pattern of joint 291 
involvement affecting either the medial or central regions of the midfoot. We therefore 292 
hypothesized that the differences in joint involvement may be reflected in the clinical 293 
and structural foot characteristics observed in clinical assessments. Overall, OA 294 
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affecting both the medial and central midfoot joints was associated with differences in 295 
symptoms, foot posture and range-of-motion compared to the no/minimal foot OA 296 
group. Overlap in the clinical characteristics of isolated medial or central midfoot OA 297 
were observed, making it challenging to differentiate these presentations on the basis 298 
of their symptoms and clinical information alone.  299 
Midfoot OA is associated with significant pain-related disability2, 4, alterations to 300 
midfoot alignment13 and reduced range-of-motion during movement8. In this study, 301 
high levels of foot pain-related disability were observed in the presence of OA across 302 
the combined medial and central midfoot regions, expanding on our previous 303 
findings4. Pain was more likely to be situated in the dorsal midfoot region, 304 
representing a new finding regarding the localisation of pain in people with midfoot 305 
OA. This is most likely explained by the close proximity of the midfoot joints to the 306 
dorsal aspect of the foot, and aggregation of bony and soft tissue changes near the 307 
joint surface37.  308 
Differences in clinical measures of foot structure such as a flatter medial longitudinal 309 
arch were also observed in this study, consistent with studies using radiological 310 
measures13, 38. Combined with higher maximum forces and pressures under the 311 
midfoot during walking in people with midfoot OA13, 14, these changes may have 312 
implications for performing activities that place significant load through the midfoot 313 
such as stair climbing8 and have been shown to relate to levels of pain-related 314 
disability14. 315 
When OA was present in both the medial and central midfoot, individuals tended to 316 
be older with a longer duration of symptoms compared to the other patterns of 317 
midfoot OA. Changes to overall foot posture indicated by the FPI score and a flatter 318 
medial arch were evident with involvement of both the medial and central midfoot 319 
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joints, whereas this was confined to a flatter medial arch in central midfoot OA. The 320 
FPI captures additional elements of foot position during standing such as abduction 321 
of the forefoot and eversion of the hindfoot. This suggests the possibility that the 322 
effect of midfoot OA on symptoms and foot structure may be cumulative and 323 
progressive in nature, with differences observed once midfoot OA is present in both 324 
medial and central regions, although prospective studies are needed. It is also 325 
possible that this reflects a greater number of midfoot joints involved or greater 326 
radiographic severity, although relationships between symptoms and clinical 327 
characteristics with the extent of OA and radiographic severity are not always 328 
consistent39. Recent evidence suggests symptoms of midfoot OA across the medial 329 
and central midfoot joints are persistent, with little change over 18 months40. Further 330 
study is required to determine whether joint involvement and foot structure in midfoot 331 
OA changes longitudinally and whether this is related to symptoms. 332 
This study also identified the presence of differences in foot function in people with 333 
midfoot OA not previously reported, including less subtalar inversion and 1st MTPJ 334 
dorsiflexion, and a higher likelihood of hallux valgus. These associated changes in 335 
the feet more generally may imply a wider-reaching impact of midfoot OA on foot 336 
function, with potential implications for the management of associated foot deformity. 337 
Although evidence from prospective studies is lacking, associations between flat foot 338 
posture with 1st MTPJ ROM, OA and hallux valgus have been reported41-43. Given 339 
that people with midfoot OA have flatter feet than those with no or minimal OA13, 16, it 340 
is possible that the mechanisms involved in the development of forefoot pathology 341 
are common to flat feet and midfoot OA. However, the temporal sequence of such 342 
proposed events cannot be determined from cross-sectional studies and prospective 343 
investigation is required to explore the long-term sequelae of midfoot OA. 344 
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Contrary to our hypothesis, limited distinction in the clinical characteristics between 345 
patterns of isolated medial and central midfoot OA were observed in this study. Only 346 
small differences in range-of-motion at the ankle and subtalar joints were present, 347 
with this varying very little (less than two degrees) according to the presence of 348 
isolated medial or isolated central midfoot OA. Larger differences were seen for the 349 
combined medial and central midfoot OA group, including measures of overall foot 350 
posture, arch height, dorsal midfoot pain, presence of hallux valgus, subtalar 351 
inversion and 1st MTPJ range-of-motion. Subsequently, identification of more 352 
extensive midfoot OA based on these clinical features may be achieved with greater 353 
confidence, with consistency of the findings across these outcomes. Although the 354 
findings indicated a tendency for greater ankle dorsiflexion and less subtalar 355 
inversion for medial midfoot OA, they do not offer any pertinent insights into potential 356 
mechanisms of disease pathogenesis for different subsets of midfoot OA. Otherwise, 357 
there was considerable overlap in clinical characteristics between feet with midfoot 358 
OA in different regions. These findings mirror challenges identified in the 359 
identification of potential phenotypes in other regions of small joint OA, such as the 360 
hand44, 45. Considerable overlap has been identified in symptoms, self-reported 361 
function and strength according to the location and distribution of OA44. From a 362 
practical standpoint, our data suggests that it is difficult to differentiate between 363 
isolated medial midfoot OA and isolated central midfoot OA on clinical grounds. The 364 
findings of this study also provide insight into clinical features more likely to 365 
distinguish combined medial and central midfoot OA, such as a more pronated 366 
overall foot posture and reduced navicular height. Therefore at present, in the 367 
absence of medical imaging, suspected midfoot OA affecting joints such as the NCJ, 368 
1st CMJ and 2nd CMJ should probably be investigated approaching these joints as a 369 
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composite unit. It is also possible that phenotypes of midfoot OA based on the 370 
pattern of joint involvement may not be detectable in the clinical setting, or that more 371 
detailed information is required to identify them. Indeed, brief clinical assessments 372 
perform poorly in diagnosing radiographic midfoot OA in individuals with midfoot 373 
pain5, highlighting the additional complexities in distinguishing subsets of midfoot OA.  374 
Recent studies of OA phenotyping at other joints with magnetic resonance imaging46, 375 
47
, pain and psychological profiling48-50 and muscle strength assessment51 present 376 
opportunities that could be applied to midfoot OA in future studies. 377 
Strengths of this study include drawing on a large community-dwelling sample of 378 
adults with foot OA and a wide range of documented clinical characteristics relating 379 
to symptoms, foot structure and function. Generalised estimating equations were 380 
used to maximise the available data from both feet, whilst accounting for between-381 
feet correlations within each person. The assessment items had well established 382 
reliability (with the exception of lower inter-rater reliability for ankle/subtalar inversion 383 
and eversion) and were reflective of the types of measurements commonly taken in 384 
clinical practice. Whilst reliability testing was not performed formally during the study, 385 
quality assurance and control were integral parts as detailed in the study protocol19. 386 
There are also limitations to be considered when interpreting the findings of this 387 
study. Midfoot OA subsets were based on the pattern of OA joint involvement in four 388 
midfoot joints due to the availability of an established and reliable radiographic atlas 389 
for these articulations. Involvement of other midfoot joints is possible and should be 390 
explored further in future studies, although reliable scoring of other joints may be 391 
problematic. Although there was a large number of total participants with foot OA, the 392 
number in each of the subgroups was smaller, reducing statistical power. Participants 393 
in this study also experienced foot pain in the past 12 months, therefore caution 394 
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should be taken extrapolating these findings to the wider population. Despite an array 395 
of clinical assessment items being undertaken, items relating to pain at specific joints 396 
in the midfoot upon palpation and movement may be more informative, albeit the 397 
reliability and clinical utility of other tests is unclear. Lastly, the exploratory nature of 398 
this analysis now warrants further investigation to substantiate the clinical 399 
significance of differences in characteristics between subsets of midfoot OA. 400 
In conclusion, this is the first detailed investigation exploring potential midfoot OA 401 
phenotypes based on the pattern of joint involvement and their associated 402 
demographic, symptomatic and clinical characteristics. Midfoot OA affecting both the 403 
medial and central joints was associated with higher levels of foot-related pain, most 404 
commonly located on the dorsal aspect of the midfoot. This was accompanied by a 405 
flatter overall foot posture, lower medial longitudinal arch, less subtalar inversion and 406 
1st MTPJ dorsiflexion. Limited distinguishing clinical characteristics existed between 407 
patterns of OA present in the medial or central midfoot, highlighting challenges in the 408 
identification of further subsets of midfoot OA in the clinical setting. Differences in 409 
alignment of the medial arch may offer potential for distinguishing midfoot OA at 410 
different sites and at different stages of disease development. Future studies are 411 
warranted to track disease progression and joint involvement in midfoot OA over time 412 
and the associated changes in symptoms and functional impairment.  413 
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Figure legends 621 
 622 
Figure 1.  Dorsoplantar radiographs depicting examples of patterns of joint 623 
involvement for feet with no or minimal OA (A), medial midfoot OA affecting the NCJ 624 
and TNJ (B), central midfoot OA in the 2nd CMJ (C), and combined medial and 625 
central midfoot OA affecting the NCJ, 1st and 2nd CMJ (D). 626 
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Table 1. Person-level characteristics (age, sex, BMI, pain ratings, MFPDI) and foot-level characteristics for groups (n=879 feet)  
 
 No or minimal  
foot OA (n=532) 
Medial midfoot OA 
(n=168) 
TNJ or NCJ or 1st CMJ  
(and no 2nd CMJ) 
Central midfoot OA 
(n=103) 
2nd CMJ only 
Combined medial and 
central midfoot OA (n=76) 
TNJ or NCJ or 1st CMJ & 2nd CMJ 
Age, years 63.7 (63.0, 64.4) 65.6 (64.2, 66.9) 66.9 (65.3, 68.6) 68.3 (66.6, 70.1) 
Sex, % female 54.7 (50.5, 58.9) 50.6 (43.0, 58.2) 63.1 (53.8, 72.4) 75.0 (65.3, 84.7) 
BMI (kg/m2) 29.7 (29.3, 30.2) 31.2 (30.3, 32.1) 30.8 (29.8, 31.8) 32.7 (31.3, 34.0) 
Manual occupation, % 51.3 (47.1, 55.6) 51.7 (44.2, 59.3) 46.6 (37.0, 56.2) 59.2 (48.2, 70.3) 
Attended higher education, % 30.6 (26.0, 33.8) 21.6 (14.2, 26.3) 26.4 (17.7, 34.7) 18.6 (9.7, 27.1) 
Joint specific OA 
    
Talonavicular joint (TNJ), n (%) 0 (0) 118 (70) 0 (0) 35 (46) 
Navicular-first cuneiform (NCJ), n (%) 0 (0) 36 (21) 0 (0) 48 (63) 
First cuneiform-metatarsal (1st CMJ), n (%) 0 (0) 33 (19) 0 (0) 17 (22) 
Second cuneiform-metatarsal (2nd CMJ), n (%) 0 (0) 0 (0) 103 (100) 76 (100) 
Foot pain and functional limitation 
    
  Foot pain severity in last month (0-10 NRS) 5.1 (4.9, 5.3) 5.5 (5.1, 5.9) 5.3 (4.8, 5.7) 5.8 (5.2, 6.3) 
  Duration of pain, %     
      < 12 months 16.8 (13.3, 20.0) 9.9 (5.0, 14.8) 12.5 (5.9, 19.1) 3.0 (0.0, 7.2) 
      1 to < 5 years 37.0 (32.5, 41.5) 39.4 (31.4, 47.5) 34.4 (24.9, 43.9) 25.8 (15.2, 36.3) 
      5 to < 10 years 16.3 (12.9, 19.8) 21.8 (15.0, 28.6) 28.1 (19.1, 37.1) 34.8 (23.4, 46.3) 
      \HDUV 29.9 (25.7, 34.2) 28.9 (21.4, 36.3) 25.0 (16.3, 33.7) 36.4 (24.8, 48.0) 
  MFPDI Pain Score -0.292 (-0.424, -0.160) -0.299 (-0.529, -0.069) 0.136 (-0.133, 0.406) 0.183 (-0.164, 0.529) 
  MFPDI Function Score -0.807 (-0.986, -0.628) -0.553 (-0.862, -0.244) -0.370 (-0.736, -0.004) 0.188 (-0.302, 0.678) 
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Table 1 continued. Person-level characteristics (age, sex, BMI, pain ratings, MFPDI) and foot-level characteristics for groups (n=879 feet) 
  
 No or minimal 
foot OA (n=532) 
Medial midfoot OA 
(n=168) 
TNJ or NCJ or 1st CMJ 
(and no 2nd CMJ) 
Central midfoot OA 
(n=103) 
2nd CMJ only 
Combined medial and 
central midfoot OA (n=76) 
TNJ or NCJ or 1st CMJ & 2nd CMJ 
Pain location and deformity 
    
  Dorsal midfoot pain, % 23.3 (19.7, 26.9) 29.1 (22.3, 36.0) 30.0 (21.2, 39.0) 48.6 (37.4, 59.9) 
  Plantar midfoot pain, % 28.3 (24.6, 32.2) 26.1 (19.5, 32.8) 24.2 (16.0, 32.6) 13.1 (5.6, 20.8) 
  Midfoot bony exostosis, % 73 (68.8, 76.3) 60.7 (53.3, 68.1) 66.9 (57.9, 76.1) 59.2 (48.2, 70.3) 
  Hallux valgus, % 28.5 (24.7, 32.4) 33.9 (26.8, 41.1) 39.8 (30.4, 49.3) 48.6 (37.4, 59.9) 
  Concurrent 1st MTPJ OA, % 3.7 (2.1, 5.4) 23.8 (17.4, 30.3) 46.6 (37.0, 56.1) 34.2 (23.5, 44.9) 
Foot posture 
    
  Foot Posture Index 2.4 (2.3, 2.6) 2.1 (1.8, 2.4) 2.9 (2.6, 3.3) 3.2 (2.8, 3.5) 
       Supinated (<0), n (%) 40 (7.5) 16 (9.5) 5 (4.9) 1 (1.3) 
       Normal (0-5) 326 (61.3) 111 (66.1) 57 (55.3) 43 (56.6) 
       3URQDWHG 166 (31.2) 41 (24.4) 41 (39.8) 32 (42.1) 
  Arch Index  0.236 (0.231, 0.240) 0.242 (0.234, 0.249) 0.268 (0.258, 0.277) 0.272 (0.262, 0.283) 
       Low arch (<0.21), n (%) 331 (62.2) 109 (64.9) 55 (53.4) 46 (60.5) 
       Normal (0.21-0.28) 75 (14.1) 30 (17.9) 36 (35.0) 26 (34.2) 
       High arch (>0.28) 126 (23.7) 29 (17.3) 12 (11.7) 4 (5.3) 
  Navicular height  0.175 (0.173, 0.178) 0.176 (0.171, 0.180) 0.162 (0.156, 0.168) 0.151 (0.143, 0.159) 
       High (>0.18-0.29), n (%) 185 (34.9) 51 (30.5) 32 (31.1) 21 (27.6) 
       Normal (>0.16-0.18) 153 (28.9) 48 (28.7) 45 (43.7) 43 (56.6) 
       Low (0.06-0.16) 192 (36.2) 68 (40.7) 26 (25.2) 12 (15.8) 
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Joint range-of-motion 
    
  Ankle joint dorsiflexion - knee extended, degreesa 62.4 (61.6, 63.2) 63.5 (62.2, 64.8) 63.1 (61.5, 64.8) 63.1 (61.4, 64.9) 
  Ankle joint dorsiflexion - knee flexed, degreesa 52.4 (51.6, 53.1) 54.4 (53.1, 55.7) 50.8 (49.2, 52.5) 54.9 (53.0, 56.8) 
  Subtalar inversion, degrees 27.4 (26.8, 28.1) 25.1 (24.0, 26.3) 27.7 (26.2, 29.2) 23.7 (21.8, 25.6) 
  Subtalar eversion, degrees 11.8 (11.3, 12.3) 10.8 (10.0, 11.7) 12.2 (11.1, 13.3) 11.9 (10.3, 13.4) 
  First MTPJ dorsiflexion, degrees 66.9 (65.4, 68.3) 63.2 (60.6, 65.8) 60.0 (56.3, 63.6) 59.4 (55.0, 63.8) 
Values are presented as mean (95% CI) unless otherwise noted. 
TNJ: talonavicular joint; NCJ: navicular-cuneiform joint; CMJ: cuneiform-metatarsal joint; OA: osteoarthritis; BMI: body mass index; MFPDI: Manchester 
Foot Pain & Disability Index; NRS: numerical rating scale; MTPJ: metatarsophalangeal joint 
a Lower values indicate greater range of motion 
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Table 2. Relationship between midfoot OA groups and clinical foot and ankle characteristics (outcomes), adjusted for age, sex, BMI and 
presence of 1st MTPJ OA.  
 
 
Medial midfoot OA 
(n=168) 
TNJ or NCJ or 1st CMJ (& no 2nd CMJ) 
Central midfoot OA  
(n=103) 
2nd CMJ only 
Combined medial & central 
midfoot OA (n=76) 
TNJ or NCJ or 1st CMJ & 2nd CMJ 
Foot pain and deformity Adjusted OR 95% CI Adjusted OR 95% CI Adjusted OR 95% CI 
Dorsal midfoot pain 1.54 1.02, 2.33 1.59 0.95, 2.66 2.54 1.45, 4.44 
Plantar midfoot pain 0.95 0.69, 1.31 0.88 0.53, 1.45 0.63 0.37, 1.06 
Midfoot bony exostosis 1.29 0.90, 1.85 1.14 0.69, 1.87 1.29 0.78, 2.15 
Hallux valgus (Y/N) 1.18 0.79, 1.75 1.04 0.60, 1.80 1.76 1.02, 3.05 
 
$GMXVWHGȕ 95% CI $GMXVWHGȕ 95% CI $GMXVWHGȕ 95% CI 
Foot pain severity in last month 0.001 -0.001, 0.003 0.000 -0.002, 0.003 0.002 -0.001, 0.005 
MFPDI Pain Score 0.000 -0.002, 0.003 0.004 0.0002, 0.008 0.004 0.0000002, 0.008 
MFPDI Function Score 0.001 -0.001, 0.002 0.001 -0.001, 0.003 0.002 -0.0003, 0.005 
Foot posture 
      
  Foot Posture Index  -0.08 -0.33, -0.16 0.19 -0.12, 0.51 0.44 0.12, 0.77 
  Arch Index  0.005 -0.002, 0.01 0.01 0.000001, 0.02 0.02 0.01, 0.03 
  Navicular height  -0.002 -0.006, 0.003 -0.006 -0.01, 0.001 -0.01 -0.01, -0.00 
Joint range-of-motion 
      
  Ankle joint dorsiflexion - knee extended, degrees 0.59 -0.54, 1.74 -0.60 -2.12, 0.90 -1.00 -2.76, 0.75 
  Ankle joint dorsiflexion - knee flexed, degrees 1.11 -0.12, 2.35 -1.46 -2.92, -0.005 -0.54 -2.57, 1.49 
  Subtalar inversion, degrees -1.71 -2.95, -0.47 0.51 -1.40, 2.42 -2.45 -4.41, -0.48 
  Subtalar eversion, degrees -0.34 -1.35, 0.67 0.91 -0.56, 2.39 0.55 -1.02, 2.13 
  First MTPJ dorsiflexion, degrees -1.71 -3.96, 0.54 -2.06 -5.10, 0.97 -4.30 -8.38, -0.21 
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Odds ratios (95% confidence intervals) are presented for binary outcome variables. Beta coefficients with 95% confidence intervals are presented for 
continuous variables. No or minimal midfoot OA is the reference category. Bold text indicates the result is considered statistically significant (odds ratio 
does not cross one or beta coefficient does not cross zero). 
TNJ: talonavicular joint; NCJ: navicular-cuneiform joint; CMJ: cuneiform-metatarsal joint; OA: osteoarthritis; MFPDI: Manchester Foot Pain and 
Disability Index. MTPJ: metatarsophalangeal joint; CI: confidence interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
